Stomach Cancer Trial, Recruiting NCT06421324 Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06421324
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with gastric intestinal metaplasia (a change in the stomach lining) or have had, or currently have, an H. pylori infection (a type of stomach bacteria)
  • You are already scheduled to have a stomach camera examination (gastroscopy) as part of your normal medical care
  • You are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • Your gastroscopy is being done to monitor or treat another condition, such as swollen veins in the food pipe, or to perform procedures like stretching the food pipe, placing a feeding tube, or removing tissue
  • You have been diagnosed with a stomach condition other than gastric intestinal metaplasia or stomach cancer
  • You have taken antibiotics at any point in the four weeks before your gastroscopy
  • You have taken proton pump inhibitors (acid-reducing medicines) or bismuth-based treatments (certain stomach medicines) within at least two weeks before your gastroscopy
  • Important information about you is not available, such as your H. pylori status, any treatment you had for H. pylori, your sex, age, whether you smoke, or whether a close family member (parent, sibling, or child) has had stomach cancer
  • You do not have the mental ability to fully understand what the study involves or to give your consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tania Fleitas, MD, PhD, Fundación para la Investigación del Hospital Clínico de Valencia

Phone: +34 689567412

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
31 July 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Risk of developing Gastric Cancer based on medical records; H. pylori Eradication Therapy Recommendation; GIM risk score assessment using imaging modalities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov